The study also revealed that patients whose tumors were highly infiltrated by both CD8+ and CD20+ cells exhibited a marginally better prognosis compared to those with high CD8+ but low CD20+ infiltration, indicating a potential supportive role of CD20+ B cells in enhancing CD8+ T cell-mediated anti-tumor immunity. The gene discussed is CD8A; the disease is neoplasm.